{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T07:45:49Z","timestamp":1789371949907,"version":"build-2803163510"},"reference-count":36,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Surg. Oncol."],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1002\/jso.24406","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T13:57:18Z","timestamp":1477663038000},"page":"779-784","source":"Crossref","is-referenced-by-count":22,"title":["The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score"],"prefix":"10.1002","volume":"114","author":[{"given":"Richard","family":"Sleightholm","sequence":"first","affiliation":[{"name":"Department of Surgery; University of Nebraska Medical Center; Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Foster","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Nebraska Medical Center; Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Nebraska Medical Center; Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Ceelen","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery; Ghent University Hospital Belgium; Gent Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Deraco","sequence":"additional","affiliation":[{"name":"National Cancer Institute of Milan; Milan Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Yildirim","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology; Aegean Obstetrics and Gynecology Education and Research Hospital; Izmir Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Levine","sequence":"additional","affiliation":[{"name":"Department of Surgery; Wake Forest University Baptist Medical Center; Winston Salem North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristobal","family":"Mu\u00f1oz-Casares","sequence":"additional","affiliation":[{"name":"Unit of Oncological and Pancreatic Surgery, Department of General and Digestive Surgery; University Hospital Reina Sofia; Cordoba Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[{"name":"Service de Chirurgie G\u00e9n\u00e9rale et Oncologique; Centre Hospitalier Lyon-Sud; Pierre-B\u00e9nite France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asish","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Surgery; University of Nebraska Medical Center; Omaha Nebraska"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Esquivel","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology; St. Agnes Hospital; Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,10,28]]},"reference":[{"key":"10.1002\/jso.24406-BIB0001|jso24406-cit-0001","unstructured":"Ferlay JSI Ervik M Dikshit R http:\/\/globocan.iarc.fr"},{"key":"10.1002\/jso.24406-BIB0002|jso24406-cit-0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ygyno.2012.05.026","article-title":"Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy","volume":"127","author":"Esselen","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24406-BIB0003|jso24406-cit-0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1245\/s10434-010-1245-3","article-title":"Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer","volume":"18","author":"Fotopoulou","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0004|jso24406-cit-0004","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","volume":"10","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1002\/jso.24406-BIB0005|jso24406-cit-0005","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1200\/JCO.2006.10.2517","article-title":"Prognostic factors for stage III epithelial ovarian cancer: A Gynecologic Oncology Group Study","volume":"25","author":"Winter","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.24406-BIB0006|jso24406-cit-0006","unstructured":"2015"},{"key":"10.1002\/jso.24406-BIB0007|jso24406-cit-0007","doi-asserted-by":"crossref","first-page":"015","DOI":"10.1007\/s11864-015-0329-5","article-title":"The role of hyperthermic intraperitoneal intraoperative chemotherapy in ovarian cancer","volume":"16","author":"van Driel","year":"2015","journal-title":"Curr Treat Options Oncol"},{"key":"10.1002\/jso.24406-BIB0008|jso24406-cit-0008","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4143\/crt.2013.45.1.40","article-title":"Feasibility of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in heavily pretreated patients with recurrent epithelial ovarian cancer","volume":"45","author":"Lee","year":"2013","journal-title":"Cancer Res Treat"},{"key":"10.1002\/jso.24406-BIB0009|jso24406-cit-0009","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","article-title":"Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer","volume":"335","author":"Alberts","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1002\/jso.24406-BIB0010|jso24406-cit-0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1002\/jso.24406-BIB0011|jso24406-cit-0011","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","article-title":"Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: An intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group","volume":"19","author":"Markman","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.24406-BIB0012|jso24406-cit-0012","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00404-014-3252-2","article-title":"Intraperitoneal chemotherapy in advanced epithelial ovarian cancer: A survey","volume":"290","author":"Grosso","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1002\/jso.24406-BIB0013|jso24406-cit-0013","first-page":"213365","article-title":"Intraoperative hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer","volume":"29","author":"Oseledchyk","year":"2015","journal-title":"Oncology"},{"key":"10.1002\/jso.24406-BIB0014|jso24406-cit-0014","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","article-title":"Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin","volume":"27","author":"Elias","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/jso.24406-BIB0015|jso24406-cit-0015","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.3747\/co.v18i2.663","article-title":"A new standard of care for the management of peritoneal surface malignancy","volume":"18","author":"Mohamed","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1002\/jso.24406-BIB0016|jso24406-cit-0016","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R","article-title":"Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis","volume":"92","author":"Ronnett","year":"2001","journal-title":"Cancer"},{"key":"10.1002\/jso.24406-BIB0017|jso24406-cit-0017","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.sla.0000231705.40081.1a","article-title":"Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"245","author":"Smeenk","year":"2007","journal-title":"Ann Surg"},{"key":"10.1002\/jso.24406-BIB0018|jso24406-cit-0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase-II trial","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1002\/jso.24406-BIB0019|jso24406-cit-0019","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s00432-014-1692-5","article-title":"Different sequential approaches of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treating ovarian cancer with malignant ascites","volume":"140","author":"Ba","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1002\/jso.24406-BIB0020|jso24406-cit-0020","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1245\/s10434-014-3693-7","article-title":"Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: A multi-institutional case control study","volume":"21","author":"Le Brun","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0021|jso24406-cit-0021","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","article-title":"Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: A French multicentre retrospective cohort study of 566 patients","volume":"39","author":"Bakrin","year":"2013","journal-title":"Eur J Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0022|jso24406-cit-0022","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/IGC.0b013e31824d836c","article-title":"Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer","volume":"22","author":"Ansaloni","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"10.1002\/jso.24406-BIB0023|jso24406-cit-0023","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1245\/s10434-014-4157-9","article-title":"Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: A prospective randomized phase III study","volume":"22","author":"Spiliotis","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0024|jso24406-cit-0024","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1002\/jso.24406-BIB0025|jso24406-cit-0025","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.ajog.2009.10.856","article-title":"Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer","volume":"202","author":"Chereau","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1002\/jso.24406-BIB0026|jso24406-cit-0026","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s004230050246","article-title":"Management of peritoneal-surface malignancy: The surgeon's role","volume":"384","author":"Sugarbaker","year":"1999","journal-title":"Langenbecks Arch Surg"},{"key":"10.1002\/jso.24406-BIB0027|jso24406-cit-0027","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7800-2-3","article-title":"Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer","volume":"2","author":"Harmon","year":"2005","journal-title":"Int Semin Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0028|jso24406-cit-0028","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.21169","article-title":"Evaluation of a peritoneal surface disease severity score in patients with colon cancer with peritoneal carcinomatosis","volume":"99","author":"Pelz","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0029|jso24406-cit-0029","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1245\/s10434-009-0866-x","article-title":"Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"17","author":"Chua","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0030|jso24406-cit-0030","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1245\/s10434-014-3798-z","article-title":"The american society of peritoneal surface malignancies (ASPSM) multiinstitution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis","volume":"21","author":"Esquivel","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0031|jso24406-cit-0031","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.ejca.2013.06.013","article-title":"Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial","volume":"49","author":"van Meurs","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1002\/jso.24406-BIB0032|jso24406-cit-0032","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1186\/1471-2407-10-689","article-title":"Evaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin","volume":"10","author":"Pelz","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1002\/jso.24406-BIB0033|jso24406-cit-0033","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jso.23679","article-title":"Evaluation of a new staging classification and a peritoneal surface disease severity score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination","volume":"110","author":"Esquivel","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0034|jso24406-cit-0034","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1245\/s10434-010-1522-1","article-title":"Influence of modern systemic therapies as adjunct to cytoreduction and perioperative intraperitoneal chemotherapy for patients with colorectal peritoneal carcinomatosis: A multicenter study","volume":"18","author":"Chua","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0035|jso24406-cit-0035","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jso.23728","article-title":"The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with mitomycin C versus oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery","volume":"110","author":"Prada-Villaverde","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1002\/jso.24406-BIB0036|jso24406-cit-0036","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1245\/s10434-015-4699-5","article-title":"Development of a prognostic nomogram for patients with peritoneally metastasized colorectal cancer treated with cytoreductive surgery and HIPEC","volume":"23","author":"Simkens","year":"2016","journal-title":"Ann Surg Oncol"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.24406","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.24406","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/jso.24406\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T02:20:20Z","timestamp":1498357220000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/jso.24406"}},"subtitle":["PSDSS Predicts Survival in OEC Patients"],"short-title":[],"issued":{"date-parts":[[2016,10,28]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"URL":"https:\/\/doi.org\/10.1002\/jso.24406","archive":["Portico"],"relation":{},"ISSN":["0022-4790"],"issn-type":[{"value":"0022-4790","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10,28]]}}}